Altria Group Inc (MO) has released its second quarter and first-half financial results for 2024. The report showcases a mix of resilience in traditional tobacco segments and promising strides in smoke-free products, reflecting Altria’s ongoing transformation to lead a smoke-free future.
Key Insights from Altria Group’s Q2 Reports:
- Altria’s second-quarter net revenues were $6.2 billion, a 4.6% decrease from Q2 2023.
- Reported diluted EPS soared by 85.7% to $2.21. This increase was primarily due to gains from in the first half of 2024, $5.8 billion was returned to shareholders. This was done through share repurchases and dividends.
- Altria has narrowed its full year adjusted diluted EPS guidance. The new range is $5.07 to $5.15.
- This range represents a growth rate of 2.5% to 4.0% from a 2023 base of $4.95.
Positive Implications for Investors:
Below are the positive implications for investors in this quarterly report.
- Strong Performance in Smoke-Free Products: Altria’s NJOY subsidiary achieved substantial milestones, receiving FDA marketing granted orders for four menthol e-vapor products. NJOY’s shipment volumes increased significantly, with consumables up by 14.7% and devices by 80.0% sequentially.
- Robust Shareholder Returns: Altria completed a $2.4 billion accelerated share repurchase program in the first half of 2024, repurchasing 53.9 million shares. Dividends amounted to $3.4 billion for the first half, reinforcing Altria’s dedication to delivering shareholder value. The company’s remaining $990 million share repurchase program is expected to be completed by the end of 2024.
Negative Implications for Investors:
Here are the bad things that this quarterly report means for investors.
- Decline in Traditional Tobacco Revenues: Altria’s smokeable products segment experienced a 5.6% decline in net revenues for Q2 2024, driven by lower shipment volumes and higher promotional investments.
- Asset Impairment Charges: Altria recorded a $354 million non-cash impairment charge for the Skoal trademark in Q2 2024, reflecting challenges in the moist smokeless tobacco segment. Such impairments can impact profitability and signal underlying market difficulties.
Stock Target Advisor’s Analysis on Altria Group:
According to Stock Target Advisor, Altria Group’s stock holds a Neutral rating based on three positive signals and three negative signals. The stock is currently priced at USD 50.55, with a one-year capital gain of 11.89%. Analysts have set an average target price of USD 46.13 over the next 12 months, suggesting a potential downside from current levels.
Conclusion:
Altria Group’s Q2 2024 earnings report presents a mixed bag of strong shareholder returns and promising growth in smoke-free products, offset by declines in traditional tobacco revenues and asset impairment charges. Investors should weigh the positive strides in smoke-free innovations and robust shareholder returns against the challenges in the traditional tobacco market and modest adjusted EPS growth.
Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product/services forecast as indicated by major brokers covering the stock.
